Association between sarcoidosis and cardiovascular Outcomes: A systematic review and Meta-analysis

Vikash Jaiswal1, Song Peng Ang2, Zouina Sarfraz3

  • 1AMA School Of Medicine, Makati, Philippines.

Insights

Patients with sarcoidosis face significantly higher risks of all-cause mortality, ventricular tachycardia, heart failure, and atrial arrhythmias. Early awareness and monitoring for cardiovascular events in sarcoidosis patients are crucial.

Area of Science:

  • Cardiology
  • Pulmonology
  • Public Health

Background:

  • Sarcoidosis is a chronic inflammatory disease with significant morbidity and mortality.
  • Cardiovascular complications in sarcoidosis are not well-documented.
  • This study investigates the association between sarcoidosis and adverse cardiovascular outcomes.

Purpose of the Study:

  • To compare the incidence of adverse cardiovascular outcomes in patients with sarcoidosis versus those without.
  • To quantify the risks of mortality, ventricular tachycardia, heart failure, and atrial arrhythmias in sarcoidosis patients.

Main Methods:

  • A systematic review and meta-analysis of studies published up to March 2022.
  • Databases searched include PubMed, Embase, and Scopus.
  • Outcomes assessed: all-cause mortality (ACM), ventricular tachycardia (VT), heart failure (HF), and atrial arrhythmias (AA).

Main Results:

  • Analysis included 6 studies with over 22 million participants.
  • Sarcoidosis patients had significantly increased all-cause mortality (RR, 2.08).
  • Higher incidence of VT (RR, 15.3), HF (RR, 4.96), and AA (RR, 2.55) observed in sarcoidosis patients.

Conclusions:

  • Patients with sarcoidosis exhibit significantly higher rates of VT, HF, and AA.
  • Cardiovascular events are a significant concern for individuals with sarcoidosis.
  • Clinicians should maintain a high index of suspicion for these adverse cardiovascular events in sarcoidosis patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
53
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
49
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
72
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
48
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
23
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
43